SCHEMBL793450

SCHEMBL793450

Clc1cc(CN2CCOCC2)cc(Cl)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.56
MAPT P10636 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CXCR4 P61073 1/20 0.49
CYP2A13 Q16696 4/20 0.47
NCF1 P14598 1/20 0.47
ALDH1A1 P00352 2/20 0.45
LMNA P02545 1/20 0.45
KCNJ1 P48048 1/20 0.45
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
NOS3 P29474 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL798244 0.89 HRH3 (0.49) HRH3MAPTSMN1; SMN2CXCR4CYP2A13
SCHEMBL20908819 0.89 CNR2 (0.51) HRH3MAPTSMN1; SMN2CXCR4CYP2A13
SCHEMBL31703257 0.85 HRH3 (0.45) HRH3MAPTSMN1; SMN2CXCR4CYP2A13
SCHEMBL32661873 0.82 HRH3 (0.56) HRH3SMN1; SMN2CXCR4NCF1ALDH1A1
SCHEMBL6033570 0.81 CXCR4 (0.49) HRH3MAPTSMN1; SMN2CXCR4CYP2A13
SCHEMBL937665 0.80 HRH3 (0.54) HRH3SMN1; SMN2CYP2A13NCF1ALDH1A1
SCHEMBL13032564 0.78 HRH3 (0.56) HRH3MAPTSMN1; SMN2CYP2A13NCF1
SCHEMBL21792875 0.78 SIGMAR1 (0.56) HRH3CXCR4MEN1KMT2ASIGMAR1
SCHEMBL20908520 0.78 MC4R (0.56) MAPTNCF1ALDH1A1LMNANPC1
SCHEMBL793723 0.78 HRH3 (0.52) HRH3MAPTSMN1; SMN2CXCR4NCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4643954-A2 NOVEL HETEROCYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Daewoong Pharmaceutical Co., Ltd. (KR) 2025-11-05 EP disclosed
US-12227498-B2 Heterocyclic amine derivative and pharmaceutical composition comprising same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2025-02-18 US disclosed
CN-115151537-B Process for preparing heterocyclic amine derivatives 株式会社大熊制药 2024-09-06 CN disclosed
CN-112638910-B New heterocyclic amine derivatives and pharmaceutical compositions containing the same 株式会社大熊制药 2024-06-11 CN disclosed
US-20230094404-A1 METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2023-03-30 US disclosed
US-20230094404-A1 METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2023-03-30 US disclosed
EP-4112617-A1 METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES Daewoong Pharmaceutical Co., Ltd. (KR) 2023-01-04 EP disclosed
EP-4112617-A1 METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES Daewoong Pharmaceutical Co., Ltd. (KR) 2023-01-04 EP disclosed
CN-115151537-A Process for preparing heterocyclic amine derivatives 株式会社大熊制药 2022-10-04 CN disclosed
CN-111212833-B Phenylpyridine derivatives and pharmaceutical compositions containing the same 株式会社大熊制药 2022-09-06 CN disclosed
EP-3696176-A1 NOVEL PHENYLPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Daewoong Pharmaceutical Co., Ltd. (KR) 2020-08-19 EP disclosed
US-20200223821-A1 Novel Phenylpyridine Derivative and Pharmaceutical Composition Comprising the Same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2020-07-16 US disclosed
US-20200223821-A1 Novel Phenylpyridine Derivative and Pharmaceutical Composition Comprising the Same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2020-07-16 US disclosed
CN-111212833-A Novel phenylpyridine derivative and pharmaceutical composition comprising same 株式会社大熊制药 2020-05-29 CN disclosed
WO-2020045941-A1 NOVEL HETEROCYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 대웅제약 2020-03-05 WO disclosed
WO-2020045941-A1 NOVEL HETEROCYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 대웅제약 2020-03-05 WO disclosed
WO-2019074275-A1 NOVEL PHENYLPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 주식회사 대웅제약 2019-04-18 WO disclosed
WO-2012035055-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-03-22 WO disclosed
WO-2012035055-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-03-22 WO disclosed
WO-2011110575-A1 DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2011-09-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230094404-A1 METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES HNMT, MAOB, PNMT HRH3 537/4885MAPT 2398/4885SMN1; SMN2 1700/4885
US-20200223821-A1 Novel Phenylpyridine Derivative and Pharmaceutical Composition Comprising the Same PDCD1, PDCD5, PDCD11 HRH3 1099/4885MAPT 1659/4885SMN1; SMN2 1892/4885
US-12227498-B2 Heterocyclic amine derivative and pharmaceutical composition comprising same H1-5, SSB, H1-2 HRH3 29/4885MAPT 4179/4885SMN1; SMN2 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.